USPTO serial 98882779
SMART MESOPOROUS BALL
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- WATSON, BRIDGET ANNE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SMART MESOPOROUS BALL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Miryang-si, KR
Miryang-si, KR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jihun Kim
Jihun Kim Bridgeway IP Law Group, PLLC11350 Random Hills RdSuite 800Fairfax, VA 22030Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of a wide range of medical conditions, namely, for treating allergies, wounds, hypertension, pain, minor inflammation, diarrhea, influenza, insomnia, dermatitis, cold, headache, cough, heartburn and indigestion; vitamin and mineral food supplements; crude medicines, namely, medicines for the treatment and prevention of atopic skin disease, obesity, digestive disorders, and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, and for skin care; radiopharmaceutical products, namely, diagnostic and therapeutic radiopharmaceutical preparations for the treatment of cancer and infectious diseases; pharmaceutical drugs for the treatment of oncological, viral, bacterial and autoimmunity diseases; medicated pastilles for pharmaceutical purposes for the treatment of cardio-vascular irregularities, gastrointestinal disorder, allergies, diarrhea, obesity, influenza, immune system disorder, immune system imbalance, anxiety disorder, stress disorder, attention-deficit hyperactivity disorder, dyslexia, sleep disorder, insomnia, chronic fatigue syndrome, irritable bowel syndrome, oral flora disorder, chronic pain, chronic inflammation, depression, headaches, osteoporosis, neuralgic pain, nervous system dysfunction, nutrient deficiency, muscle pain, neurodermatitis, dermatitis, skin injury, mucosal disease, kidney disease, liver disease, biliary disease, gastric acid disorder, hormone disorder, joint pain, post-Covid syndrome, concentration and memory disorder, cough, ear disease, nose disease, throat disease, and sore throat; medicated lotions for pharmaceutical purposes, namely, burn relief lotions, lotions for wound treatment, and lotions for allergy treatment; chemical preparations for pharmaceutical use, namely, for the treatment of neurodegenerative disorders, neurological conditions, cancer, skin conditions, fungal, viral, bacterial and infectious diseases, and for use in wound healing or photodynamic therapy | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2026 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 24, 2026 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 20, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Nov 25, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 25, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 19, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 24, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 3, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 3, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 3, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 22, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 3, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 3, 2024 | NWAP | NEW APPLICATION ENTERED | — |